Becker's Healthcare May 6, 2024
The FDA is urging drug companies to pinpoint the cancer drug dosage that has the greatest impact with the fewest side effects. Its most recent study scrutinizes the dosage of a lung cancer drug, The Washington Post reported May 6.
Typically, companies spend the first series of drug trials escalating doses in small groups of patients until about a quarter of them become seriously ill. That “maximum tolerated dose” is used in more advanced clinical trials and tends to make it to the drug’s label, according to the report. However, the FDA is asking companies to reassess.
The presence of more side effects means more patients become ill and skip doses or stop taking drugs altogether. In some cases, a...
Today's Sponsors
Today's Sponsor